{"a":[{"_":"Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay","$":{"href":"/sponsored/advancing-mcspc-treatment-closer-look-adt-darolutamide-dr-rana-mckay","hreflang":"en"}}]}

Summary

Dr. Rana McKay discusses the ARANOTE trial of NUBEQA (darolutamide) in combination with ADT for metastatic castration-sensitive prostate cancer treatment. This is a sponsored speaker content piece without new trial results or material announcements.